Micronization of Salbutamol Sulfate by Supercritical Antisolvent Precipitation: The Effect of Process Parameters on the Size and Morphology of Particles


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A study was made of the applicability of supercritical antisolvent precipitation to producing microparticles of the antiasthmatic drug salbutamol sulfate that are suitable for manufacturing the drug in inhalation dosage form. Depending on the salbutamol concentration in the initial solution, the flow rate of the solution, and pressure, either spherical or needle-like particles 0.7–8.5 μm in size form. The dependence of the average particle size on the salbutamol concentration in the initial solution is nonmonotonic. The conditions were determined under which the obtained salbutamol particles meet the shape and size requirements for fabrication of inhalation dosage forms.

About the authors

A. M. Vorobei

Kurnakov Institute of General and Inorganic Chemistry; Moscow State University

Author for correspondence.
Email: vorobei@supercritical.ru
Russian Federation, Moscow, 119991; Moscow, 119991

O. I. Pokrovskiy

Kurnakov Institute of General and Inorganic Chemistry

Email: vorobei@supercritical.ru
Russian Federation, Moscow, 119991

K. B. Ustinovich

Kurnakov Institute of General and Inorganic Chemistry

Email: vorobei@supercritical.ru
Russian Federation, Moscow, 119991

O. O. Parenago

Kurnakov Institute of General and Inorganic Chemistry; Moscow State University

Email: vorobei@supercritical.ru
Russian Federation, Moscow, 119991; Moscow, 119991

V. V. Lunin

Kurnakov Institute of General and Inorganic Chemistry; Moscow State University

Email: vorobei@supercritical.ru
Russian Federation, Moscow, 119991; Moscow, 119991

A. G. Miroshnichenko

Siberian State Medical University

Email: vorobei@supercritical.ru
Russian Federation, Tomsk, 634050

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Ltd.